Rapid Micro Biosystems (RPID)
(Delayed Data from NSDQ)
$3.41 USD
-0.01 (-0.29%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $3.43 +0.02 (0.59%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
RPID 3.41 -0.01(-0.29%)
Will RPID be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for RPID based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RPID
908 Devices Inc. (MASS) Reports Q2 Loss, Tops Revenue Estimates
Thermo Fisher Scientific (TMO) Tops Q2 Earnings and Revenue Estimates
RPID: What are Zacks experts saying now?
Zacks Private Portfolio Services
Rapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue Estimates
LivaNova (LIVN) Q1 Earnings and Revenues Surpass Estimates
Rapid Micro Biosystems, Inc. (RPID) Reports Q4 Loss, Tops Revenue Estimates
Other News for RPID
Rapid Micro Biosystems to Announce Second Quarter 2025 Financial Results on August 12, 2025 | ...
Lake Street Initiates Coverage on Rapid Micro Biosystems (RPID) with Buy Rating | RPID Stock News
Lake Street Initiates Coverage on Rapid Micro Biosystems (RPID) with Positive Outlook
Rapid Micro Biosystems initiated with bullish view at Lake Street, here's why
Rapid Micro Biosystems: Benefiting From Partnership With Merck; Initiating With 'Buy'